Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docecal vs Taxotere in breast cancer
2012-005161-12Phase 3Terminated
- Sponsor
- Vivesto AB
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of calcium carbonate + cholecalciferol in breast cancer, sponsored by Vivesto AB. Started Aug 2015; status: terminated.
02
Drugs
calcium carbonate + cholecalciferol
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2012-005161-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005161-12.